Stem cells are naturally anti-inflammatory, but often do not survive or function long enough to exert full therapeutic benefit. Inflammatory and immune diseases, such as type I diabetes, arthritis, multiple sclerosis, lupus, Crohn’s disease, inflammatory bowel diseases and graft-versus-host disease, arise due to pathogens, damaged host cells, or defects in the regulation of inflammatory pathways, and result in chronic tissue damage and dysfunction. Current drug treatment regimens for these diseases are often ineffective and clinical success varies greatly between patients. Read More